Interviews
By Company
Addex Pharmaceuticals
Addex Pharmaceuticals and the Pursuit of the True Innovation
May 2008
In this conversation with Dr. Vincent Mutel, co-founder and CEO of Addex Pharmaceuticals, Fintan Walton reveals how the Addex mission—to achieve true innovation—has contributed to the tremendous success of this young biotech company.
Apposite Capital
Apposite Capital: Ready to Take the Lead in Life Science Investments
May 2008
In this interview, Fintan Walton talks to Dr. Allan Marchington, partner in Apposite Capital.
Archimedes Pharma Ltd
Richard de Souza, Chief Executive Officer, Archimedes Pharma
October 2006
Interview with Richard de Souza, Archimedes Pharma
Archimedes: A Thriving Speciality Pharma
April 2008
In this new interview, Fintan Walton talks to Richard de Souza, CEO of Archimedes Pharma.
AstraZeneca plc
Rob Hockney, Director of Alliance Management, Global Discovery Alliances, AstraZeneca
November 2006
Special Interview with Rob Hockney, AstraZeneca
The Pharmaceutical Outlook for 2007 - A US Perspective
May 2007
An interview with Tom Quinlan and Matthew Gardner
Impact of US Presidential Elections on Biotech
February 2008
In this exclusive interview, Fintan Walton and Matt Gardner, President and CEO of BayBio, look back on 2007
Bioscience Managers
The Pharmaceutical Outlook for 2007 - An EU Perspective
April 2007
An interview with Jeremy Curnock Cook, John Wilkinson and Jim McCarthy
Biota
Peter Cook, CEO and Managing Director, Biota
November 2006
Special Edition of PharmaVentures Business Review
BioXcel Corp
India, an increasingly important role in the Life Science Business
April 2007
Interview with Krishnan Nandu Nadabalan and Vimal Mehta
Bird & Bird
Competition Law in the Pharmaceutical Industry: a Bird & Bird View
April 2008
In this exclusive interview Fintan Walton talks to Richard Eccles, Partner at law firm Bird & Bird.
Borean Pharma ApS
Novel Protein Technology Opens Doors to Danish Biotech Company
July 2007
Interview with Johanna Holldack
Bristol-Myers Squibb
Bristol-Myers Squibb: Business Development in a Global Community
November 2007
Interview with Graham Brazier
Celltech plc
Celltech: The birth of the European biotechnology industry
April 2007
Interview with Gerard Fairtlough
Chemeq Ltd
Meet the Experts Special: Biotech in Australia and New Zealand
January 2007
Pharmaventures Business Review Special
Emerging Growth Capital (eG Capital) Pty Ltd
Australian Biotech: A 2007 Perspective from Alison Coutts
December 2007
Interview with Alison Coutts
EUSA Pharma
Strategies of a Speciality Company: EUSA Pharma
April 2008
In this exclusive interview, Fintan Walton talks to Bryan Morton, Founder and CEO of EUSA Pharma.
Evotec AG
Dr Mark Ashton, Executive Vice President Business Development, Evotec
October 2006
Interview with Dr Mark Ashton, Evotec
Gilead Sciences Ltd
Gilead Sciences: Ireland - Much More than just a Portal to the EU Market
July 2008
In this interview, Fintan Walton talks to Julie O'Neill, General Manager of Gilead Sciences Ltd
Glide Pharmaceutical Technologies Ltd
Glide Pharma: The transition from drug delivery to specialty pharma
February 2007
Special Interview with Charles Potter, Glide Pharma
Indiana Economic Development Corporation (IEDC)
Indiana: A Bioscience Centre of Excellence
January 2008
Interview with Stephen Patillo and David Boncosky
Irish Development Agency (IDA)
Biopharma in Ireland: In Pursuit of Quality by Design
June 2008
In this panel discussion, Fintan Walton talks with key executives in Ireland.
A Word from the CEO of IDA, Barry O'Leary
June 2008
In this interview, Fintan Walton talks to Barry O'Leary, CEO of IDA
Gilead Sciences: Ireland - Much More than just a Portal to the EU Market
July 2008
In this interview, Fintan Walton talks to Julie O'Neill, General Manager of Gilead Sciences Ltd
Johnson & Johnson Research
Australia's Johnson & Johnson Research: Working within a Global Organisation
November 2007
Interview with Dr Susan Pond
Karus Therapeutics
Karus Therapeutics: Better Medicines from Selective HDAC Inhibitors
June 2008
In this interview, Fintan Walton talks with Simon Kerry, CEO of Karus Therapeutics
London Genetics Ltd
London Genetics: Bridging the Gap
March 2008
In this exclusive interview, Fintan Walton talks to Nick Lench, CEO of London Genetics.
Maryland Department of Business and Economic Development (DBED)
Choose Maryland: Will this US State be the Next Silicon Valley?
May 2008
In this interview Fintan Walton speaks with Lawrence Mahan, Senior Strategy Advisor for Biosciences for the state of Maryland, and Richard Zakour, Executive Director of MdBio.
McKenna Long & Aldridge
Successful Partnering with the US Government through Funding for Bio-Threat Research and Development
December 2007
Interview with John Clerici
Mercury Therapeutics
Mercury Therapeutics: Novel approaches in the treatment of Type 2 diabetes
June 2008
In this interview, Fintan Walton talks with Dr. Neal Birnberg, CEO of Mercury Therapeutics, and Stan Yakatan, Chairman of Mercury’s Board of Directors.
Novartis’ Latest Antibody Deal with MorphoSys – Exclusive TV Interview
December 2007
Interview with Simon Moroney
Nektar
Inhaling Success: An Interview with John Patton, CSO and Co-founder of Nektar Therapeutics.
February 2007
Interview with John Patton
NicOx SA
The Rise of NicOx: An Interview with Damian Marron, VP Corporate Development, NicOx
April 2007
Interview with Damian Marron
NovaQuest
NovaQuest: Principles and Strategies
March 2008
In this exclusive interview, Fintan Walton talks to Ben Cons, Vice President of NovaQuest.
Novarix Ltd
Interview with Lise Kagenow: Inventor and Entrepreneur
March 2008
In this exclusive interview, Fintan Walton talks to Lise Kagenow, Managing Director of Novarix.
Otago Innovation
Meet the Experts Special: Biotech in Australia and New Zealand
January 2007
Pharmaventures Business Review Special
Oxford BioMedica plc
Vector Value: An Interview with Nick Woolf, SVP Corporate Strategy, Oxford BioMedica
May 2007
An Interview with Nick Woolf, SVP Corporate Strategy, Oxford BioMedica
The Pharmaceutical Outlook for 2007 - An EU Perspective
April 2007
An interview with Jeremy Curnock Cook, John Wilkinson and Jim McCarthy
Reed Smith
The Pharmaceutical Outlook for 2007 - An EU Perspective
April 2007
An interview with Jeremy Curnock Cook, John Wilkinson and Jim McCarthy
The Pharmaceutical Outlook for 2007 - A US Perspective
May 2007
An interview with Tom Quinlan and Matthew Gardner
Roche
Alliance Management: An Exclusive Interview with Roche
November 2006
An interview with Eric de La Fortelle
Roche Restructuring: An Exclusive Interview with Eric de La Fortelle, F. Hoffmann-La Roche
May 2007
Interview with Eric de La Fortelle
Sareum Ltd
Sareum and Structure: An Interview with Tim Mitchell, CEO, Sareum
March 2007
Interview with Tim Mitchell
Simcere Pharmaceuticals, Inc.
Dr H Ming Pang (Head of International Business - Simcere Pharmaceuticals, Inc., Director - Eastway Consultants Ltd HK)
October 2006
Interview with Dr H Ming Pang, Simcere Pharmaceuticals
Simmons & Simmons
Licensing Deals and Acquisitions: A Legal Insight
November 2007
Interview with Marc Fredj and Richard Wallis
Speedel Pharma
Dr Alice Huxley, CEO & President, Speedel
December 2006
Special Interview with Alice Huxley, Speedel
Speedel’s Renin Inhibitor Success Story
February 2008
Fintan Walton talks to Alice Huxley, CEO of the Swiss biopharmaceutical company Speedel
Synosia Therapeutics
Roche:Synosia Deal - Birth of an Innovative Business Strategy
February 2007
Special Interview with Synosia Therapeutics
Synta Pharmaceuticals Corp.
Synta Pharmaceuticals: Strategy and Pipeline
March 2008
In this exclusive interview, Fintan Walton talks to Safi Bahcall, President and CEO of Synta Pharmaceuticals.
Takeda Research Investment
Takeda Research Investment: Reaching Beyond the Land of the Rising Sun
May 2008
This insightful conversation features Graeme Martin, CEO of Takeda Research Investment (TRI)—the corporate venture arm of Takeda Pharmaceutical.
The GI Company
The GI Company: Specialists in GI Medicine
May 2008
In this interview, Fintan Walton talks to Nicholas Barker, President and CEO of The GI Company.
The Tech Council of Maryland/MdBio (TCM/MdBio)
Choose Maryland: Will this US State be the Next Silicon Valley?
May 2008
In this interview Fintan Walton speaks with Lawrence Mahan, Senior Strategy Advisor for Biosciences for the state of Maryland, and Richard Zakour, Executive Director of MdBio.
ValiRx
ValiRx: Bioscience Innovation
June 2008
In this interview, Fintan Walton talks with Satu Vainikka, CEO of ValiRx
Zogenix, Inc.
Stephen Farr, President & COO, and Jonathan Rigby, VP Business Development, Zogenix.
November 2006
Special Edition of PharmaVentures Business Review
ZymoGenetics, Inc.
25 Years Young: An Interview with Bruce Carter, President and CEO of ZymoGenetics.
July 2006
Interview with Bruce Carter
